{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:53:25Z","timestamp":1782658405717,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bmc.2021.116293","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T04:13:24Z","timestamp":1624594404000},"page":"116293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5"],"prefix":"10.1016","volume":"44","author":[{"given":"Jia","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iohong","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116293_b0005","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmc.2021.116293_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.bmc.2021.116293_b0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2021.116293_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bmc.2021.116293_b0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mib.2011.06.001","article-title":"Mucosal biofilms of Candida albicans","volume":"14","author":"Ganguly","year":"2011","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bmc.2021.116293_b0030","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2021.116293_b0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bmc.2021.116293_b0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","article-title":"Antifungals","volume":"133","author":"Campoy","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2021.116293_b0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/tcrm.2007.3.1.71","article-title":"Comparison of echinocandin antifungals","volume":"3","author":"Eschenauer","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.bmc.2021.116293_b0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.chembiol.2011.01.009","article-title":"Confronting the challenges of natural product-based antifungal discovery","volume":"18","author":"Roemer","year":"2011","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2021.116293_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/antibiotics8030087","article-title":"Regulation of geldanamycin biosynthesis by cluster-situated transcription factors and the master regulator PhoP","volume":"8","author":"Mart\u00edn","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2021.116293_b0060","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/S0021-9258(17)42019-9","article-title":"Mechanism of cyclosporin A biosynthesis. Evidence for synthesis via a single linear undecapeptide precursor","volume":"269","author":"Dittmann","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2021.116293_b0065","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1073\/pnas.0609370104","article-title":"High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2021.116293_b0070","series-title":"Frontiers in Pharmacology 9","article-title":"A review on the synthesis and bioactivity aspects of beauvericin, a Fusarium mycotoxin","author":"Wu","year":"2018"},{"key":"10.1016\/j.bmc.2021.116293_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2021.116293_b0080","doi-asserted-by":"crossref","unstructured":"Su TCGfRotSoQH. 1977. A new sesquiterpene lactone-Qinghaosu. Chin Sci Bull. 22:142.","DOI":"10.1360\/csb1977-22-3-142"},{"key":"10.1016\/j.bmc.2021.116293_b0085","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2021.116293_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107658","article-title":"The birth of artemisinin","author":"Ma","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2021.116293_b0095","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2021.116293_b0100","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/np050074u","article-title":"Antifungal activity of artemisinin derivatives","volume":"68","author":"Galal","year":"2005","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2021.116293_b0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: Pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2021.116293_b0110","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1073\/pnas.1911560116","article-title":"Mitochondrial dysfunctions trigger the calcium signaling-dependent fungal multidrug resistance","volume":"117","author":"Li","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2021.116293_b0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jchromb.2007.01.012","article-title":"An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study","volume":"852","author":"Kim","year":"2007","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.bmc.2021.116293_b0120","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jpba.2009.06.030","article-title":"Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection","volume":"50","author":"Gordien","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.bmc.2021.116293_b0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.bmc.2021.116293_b0130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/EC.2.5.1053-1060.2003","article-title":"Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection","volume":"2","author":"Saville","year":"2003","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bmc.2021.116293_b0135","doi-asserted-by":"crossref","unstructured":"Sanglard D. 2016. Emerging threats in antifungal-resistant fungal pathogens. Frontiers in Medicine 3.","DOI":"10.3389\/fmed.2016.00011"},{"key":"10.1016\/j.bmc.2021.116293_b0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2021.116293_b0145","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/EC.00091-07","article-title":"Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae","volume":"6","author":"Lamping","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bmc.2021.116293_b0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nmeth.1550","article-title":"Knocking out multigene redundancies via cycles of sexual assortment and fluorescence selection","volume":"8","author":"Suzuki","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.bmc.2021.116293_b0155","doi-asserted-by":"crossref","first-page":"31543","DOI":"10.1074\/jbc.271.49.31543","article-title":"Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p","volume":"271","author":"Kolaczkowski","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2021.116293_b0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd1382","article-title":"Key factors in the rising cost of new drug discovery and development","volume":"3","author":"Dickson","year":"2004","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bmc.2021.116293_b0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bmc.2021.116293_b0170","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","article-title":"Qinghaosu (artemisinin): The price of success","volume":"320","author":"White","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bmc.2021.116293_b0175","unstructured":"WHO. World malaria report 2019."},{"key":"10.1016\/j.bmc.2021.116293_b0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","article-title":"Antimalarial drugs as immune modulators: New mechanisms for old drugs","volume":"68","author":"An","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bmc.2021.116293_b0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pt.2020.10.003","article-title":"Repurposing antimalarials to tackle the COVID-19 pandemic","volume":"37","author":"Krishna","year":"2021","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmc.2021.116293_b0190","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: A multicentre, open-label, randomised clinical trial","volume":"395","author":"van der","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2021.116293_b0195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mib.2013.03.005","article-title":"The fungal Achilles' heel: Targeting Hsp90 to cripple fungal pathogens","volume":"16","author":"Cowen","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bmc.2021.116293_b0200","doi-asserted-by":"crossref","unstructured":"Simm C, May RC. 2019. Zinc and iron homeostasis: Target-based drug screening as new route for antifungal drug development. Front Cell Infect Microbiol. 9.","DOI":"10.3389\/fcimb.2019.00181"},{"issue":"1","key":"10.1016\/j.bmc.2021.116293_b0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/mdr.2009.0854","article-title":"Modulation of the antifungal activity of new medicinal plant extracts active on Candida glabrata by the major transporters and regulators of the pleiotropic drug-resistance network in Saccharomyces cerevisiae","volume":"15","author":"Kolaczkowski","year":"2009","journal-title":"Microbial Drug Resistance"},{"key":"10.1016\/j.bmc.2021.116293_b0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.04229-14","article-title":"Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms","volume":"59","author":"De Cremer","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:14:29Z","timestamp":1760836469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621003011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S0968089621003011"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116293","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116293"}}